Continuous nebulization of inhaled $\beta$ agonists has been used for

Question

Quizplus · Accepted Answer

The administration of inhaled adrenergic agents by continuous nebulization has been used for management of severe asthma,in an effort to avoid respiratory failure,intubation,and mechanical ventilation.The Guidelines for the Diagnosis and Management of Asthma released by the 2007 National Asthma Education and Prevention Expert Panel Report 2 (NAEPP EPR 2)also recommend 2.5 to 5 mg of albuterol by nebulizer every 20 minutes for three doses and 10 to 15 mg/hr by continuous nebulization.Because a nebulizer treatment takes approximately 10 minutes,giving three treatments every 20 minutes requires repeated therapist attendance.Continuous administration by nebulizer may simplify such frequent treatments.Pneumonia is an interstitial process,and unless there is a bronchoconstrictive component to the disease,a F1F1F1S1?F1F1F10 agonist would be of little use.Cystic fibrosis is a chronic disease,and although a $\beta$ agonist may be useful to reverse any accompanying bronchoconstriction,its use as a continually nebulized medication is unwarranted.Similar to cystic fibrosis,emphysema is a chronic disease process,and unless the patient is having an acute episode accompanied by bronchoconstriction,continuous nebulization would be unwarranted.

Continuous Nebulization of Inhaled β\betaβ Agonists Has Been Used for A)severe Asthma

Continuous Nebulization of Inhaled $\beta$ Agonists Has Been Used for
A)severe Asthma